Cargando…

The Chemokine Receptor CXCR4 and c-MET Cooperatively Promote Epithelial-Mesenchymal Transition in Gastric Cancer Cells

The C-X-C motif chemokine receptor 4 (CXCR4) pathway can promote tumor metastasis but is dependent on cross talk with other signaling pathways. The MET proto-oncogene (c-MET) participates in metastasis and is highly expressed in gastric cancer. However, the relationship between CXCR4 and c-MET signa...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Yu, Song, Yongxi, Qu, Jinglei, Che, Xiaofang, Song, Na, Fan, Yibo, Wen, Ti, Xu, Ling, Gong, Jing, Wang, Xiaoxun, Zhang, Chenlu, Qu, Xiujuan, Liu, Yunpeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5884220/
https://www.ncbi.nlm.nih.gov/pubmed/29494948
http://dx.doi.org/10.1016/j.tranon.2018.02.002
_version_ 1783311783472136192
author Cheng, Yu
Song, Yongxi
Qu, Jinglei
Che, Xiaofang
Song, Na
Fan, Yibo
Wen, Ti
Xu, Ling
Gong, Jing
Wang, Xiaoxun
Zhang, Chenlu
Qu, Xiujuan
Liu, Yunpeng
author_facet Cheng, Yu
Song, Yongxi
Qu, Jinglei
Che, Xiaofang
Song, Na
Fan, Yibo
Wen, Ti
Xu, Ling
Gong, Jing
Wang, Xiaoxun
Zhang, Chenlu
Qu, Xiujuan
Liu, Yunpeng
author_sort Cheng, Yu
collection PubMed
description The C-X-C motif chemokine receptor 4 (CXCR4) pathway can promote tumor metastasis but is dependent on cross talk with other signaling pathways. The MET proto-oncogene (c-MET) participates in metastasis and is highly expressed in gastric cancer. However, the relationship between CXCR4 and c-MET signaling and their mechanisms of action in gastric cancer metastasis remain unclear. In this study, in vitro experiments demonstrated that C-X-C motif chemokine ligand 12 (CXCL12)/CXCR4 induces epithelial-mesenchymal transition (EMT) and promotes migration in gastric cancer cells, which is accompanied by c-MET activation. These phenomena were reversed by c-MET inhibition. Further investigation revealed that c-MET activation correlated with its interaction with caveolin 1 in lipid rafts, induced by CXCL12. In clinical samples, we observed a significant positive association between CXCR4 expression and c-MET phosphorylation (r = 0.259, P = .005). Moreover, samples expressing both receptors were found to indicate significantly poorer patient prognosis (P < .001). These results suggest that CXCL12 induces EMT at least partially through cross talk between CXCR4 and c-MET signaling. In addition, changes in these pathways could have clinical importance for the treatment of gastric cancer.
format Online
Article
Text
id pubmed-5884220
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Neoplasia Press
record_format MEDLINE/PubMed
spelling pubmed-58842202018-04-06 The Chemokine Receptor CXCR4 and c-MET Cooperatively Promote Epithelial-Mesenchymal Transition in Gastric Cancer Cells Cheng, Yu Song, Yongxi Qu, Jinglei Che, Xiaofang Song, Na Fan, Yibo Wen, Ti Xu, Ling Gong, Jing Wang, Xiaoxun Zhang, Chenlu Qu, Xiujuan Liu, Yunpeng Transl Oncol Original article The C-X-C motif chemokine receptor 4 (CXCR4) pathway can promote tumor metastasis but is dependent on cross talk with other signaling pathways. The MET proto-oncogene (c-MET) participates in metastasis and is highly expressed in gastric cancer. However, the relationship between CXCR4 and c-MET signaling and their mechanisms of action in gastric cancer metastasis remain unclear. In this study, in vitro experiments demonstrated that C-X-C motif chemokine ligand 12 (CXCL12)/CXCR4 induces epithelial-mesenchymal transition (EMT) and promotes migration in gastric cancer cells, which is accompanied by c-MET activation. These phenomena were reversed by c-MET inhibition. Further investigation revealed that c-MET activation correlated with its interaction with caveolin 1 in lipid rafts, induced by CXCL12. In clinical samples, we observed a significant positive association between CXCR4 expression and c-MET phosphorylation (r = 0.259, P = .005). Moreover, samples expressing both receptors were found to indicate significantly poorer patient prognosis (P < .001). These results suggest that CXCL12 induces EMT at least partially through cross talk between CXCR4 and c-MET signaling. In addition, changes in these pathways could have clinical importance for the treatment of gastric cancer. Neoplasia Press 2018-02-27 /pmc/articles/PMC5884220/ /pubmed/29494948 http://dx.doi.org/10.1016/j.tranon.2018.02.002 Text en © 2018 The Authors. Published by Elsevier Inc. on behalf of Neoplasia Press, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original article
Cheng, Yu
Song, Yongxi
Qu, Jinglei
Che, Xiaofang
Song, Na
Fan, Yibo
Wen, Ti
Xu, Ling
Gong, Jing
Wang, Xiaoxun
Zhang, Chenlu
Qu, Xiujuan
Liu, Yunpeng
The Chemokine Receptor CXCR4 and c-MET Cooperatively Promote Epithelial-Mesenchymal Transition in Gastric Cancer Cells
title The Chemokine Receptor CXCR4 and c-MET Cooperatively Promote Epithelial-Mesenchymal Transition in Gastric Cancer Cells
title_full The Chemokine Receptor CXCR4 and c-MET Cooperatively Promote Epithelial-Mesenchymal Transition in Gastric Cancer Cells
title_fullStr The Chemokine Receptor CXCR4 and c-MET Cooperatively Promote Epithelial-Mesenchymal Transition in Gastric Cancer Cells
title_full_unstemmed The Chemokine Receptor CXCR4 and c-MET Cooperatively Promote Epithelial-Mesenchymal Transition in Gastric Cancer Cells
title_short The Chemokine Receptor CXCR4 and c-MET Cooperatively Promote Epithelial-Mesenchymal Transition in Gastric Cancer Cells
title_sort chemokine receptor cxcr4 and c-met cooperatively promote epithelial-mesenchymal transition in gastric cancer cells
topic Original article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5884220/
https://www.ncbi.nlm.nih.gov/pubmed/29494948
http://dx.doi.org/10.1016/j.tranon.2018.02.002
work_keys_str_mv AT chengyu thechemokinereceptorcxcr4andcmetcooperativelypromoteepithelialmesenchymaltransitioningastriccancercells
AT songyongxi thechemokinereceptorcxcr4andcmetcooperativelypromoteepithelialmesenchymaltransitioningastriccancercells
AT qujinglei thechemokinereceptorcxcr4andcmetcooperativelypromoteepithelialmesenchymaltransitioningastriccancercells
AT chexiaofang thechemokinereceptorcxcr4andcmetcooperativelypromoteepithelialmesenchymaltransitioningastriccancercells
AT songna thechemokinereceptorcxcr4andcmetcooperativelypromoteepithelialmesenchymaltransitioningastriccancercells
AT fanyibo thechemokinereceptorcxcr4andcmetcooperativelypromoteepithelialmesenchymaltransitioningastriccancercells
AT wenti thechemokinereceptorcxcr4andcmetcooperativelypromoteepithelialmesenchymaltransitioningastriccancercells
AT xuling thechemokinereceptorcxcr4andcmetcooperativelypromoteepithelialmesenchymaltransitioningastriccancercells
AT gongjing thechemokinereceptorcxcr4andcmetcooperativelypromoteepithelialmesenchymaltransitioningastriccancercells
AT wangxiaoxun thechemokinereceptorcxcr4andcmetcooperativelypromoteepithelialmesenchymaltransitioningastriccancercells
AT zhangchenlu thechemokinereceptorcxcr4andcmetcooperativelypromoteepithelialmesenchymaltransitioningastriccancercells
AT quxiujuan thechemokinereceptorcxcr4andcmetcooperativelypromoteepithelialmesenchymaltransitioningastriccancercells
AT liuyunpeng thechemokinereceptorcxcr4andcmetcooperativelypromoteepithelialmesenchymaltransitioningastriccancercells
AT chengyu chemokinereceptorcxcr4andcmetcooperativelypromoteepithelialmesenchymaltransitioningastriccancercells
AT songyongxi chemokinereceptorcxcr4andcmetcooperativelypromoteepithelialmesenchymaltransitioningastriccancercells
AT qujinglei chemokinereceptorcxcr4andcmetcooperativelypromoteepithelialmesenchymaltransitioningastriccancercells
AT chexiaofang chemokinereceptorcxcr4andcmetcooperativelypromoteepithelialmesenchymaltransitioningastriccancercells
AT songna chemokinereceptorcxcr4andcmetcooperativelypromoteepithelialmesenchymaltransitioningastriccancercells
AT fanyibo chemokinereceptorcxcr4andcmetcooperativelypromoteepithelialmesenchymaltransitioningastriccancercells
AT wenti chemokinereceptorcxcr4andcmetcooperativelypromoteepithelialmesenchymaltransitioningastriccancercells
AT xuling chemokinereceptorcxcr4andcmetcooperativelypromoteepithelialmesenchymaltransitioningastriccancercells
AT gongjing chemokinereceptorcxcr4andcmetcooperativelypromoteepithelialmesenchymaltransitioningastriccancercells
AT wangxiaoxun chemokinereceptorcxcr4andcmetcooperativelypromoteepithelialmesenchymaltransitioningastriccancercells
AT zhangchenlu chemokinereceptorcxcr4andcmetcooperativelypromoteepithelialmesenchymaltransitioningastriccancercells
AT quxiujuan chemokinereceptorcxcr4andcmetcooperativelypromoteepithelialmesenchymaltransitioningastriccancercells
AT liuyunpeng chemokinereceptorcxcr4andcmetcooperativelypromoteepithelialmesenchymaltransitioningastriccancercells